Cargando…
MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice
BACKGROUND: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the presence of pathogenic autoantibodies. Recent studies suggest that microRNAs (miRNAs) play an essential role in immunoregulation and may be involved in the pathogenesis of SLE. Therefore, it was of in...
Autores principales: | Pan, Yang, Jia, Tingting, Zhang, Yuan, Zhang, Kuo, Zhang, Rui, Li, Jinming, Wang, Lunan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518289/ https://www.ncbi.nlm.nih.gov/pubmed/23233803 http://dx.doi.org/10.2147/IJN.S37990 |
Ejemplares similares
-
Using a Novel MicroRNA Delivery System to Inhibit Osteoclastogenesis
por: Yao, Yanlan, et al.
Publicado: (2015) -
Choroidal Thickness and microRNA146 in Lupus Nephritis Patients
por: Hassan Salah, Shaymaa, et al.
Publicado: (2020) -
Choroidal Thickness and microRNA146 in Lupus Nephritis Patients [Letter]
por: Capasso, Luigi, et al.
Publicado: (2020) -
Autoantibodies against the Catalytic Domain of BRAF Are Not Specific Serum Markers for Rheumatoid Arthritis
por: Li, Wenli, et al.
Publicado: (2011) -
Delivery of microRNA-146a with polyethylenimine nanoparticles inhibits renal fibrosis in vivo
por: Morishita, Yoshiyuki, et al.
Publicado: (2015)